[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352486-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352486-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exosomes-and-triple-negative-breast-cancer-current-knowledge-and-clinical-significance","Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance","","Exosomes are vital mediators of cellular communication, carrying diverse biomolecular cargo and contributing to cancer pathogenesis and progression. For triple-negative breast cancer (TNBC), where treatment options remain challenging, the search for non-invasive biomarkers is critical. This systematic review synthesizes recent evidence on exosomal biomarkers for diagnosing TNBC, predicting prognosis, and anticipating treatment response, emphasizing liquid biopsy potential alongside key barriers to clinical translation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exosomes-and-triple-negative-breast-cancer-current-knowledge-and-clinical-significance/352486/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exosomes-and-triple-negative-breast-cancer-current-knowledge-and-clinical-significance/352486.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do exosomes contribute to cellular communication relevant to cancer?","Question",{"text":63,"@type":64},"Exosomes are nanovesicles that mirror the state of their parent cells and transfer information to distant cells and tissues. When cellular equilibrium is disrupted, such as in cancer, exosomes can foster pathological processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why are exosomal biomarkers considered important for TNBC patients?",{"text":68,"@type":64},"TNBC faces significant therapeutic hurdles, making new non-invasive biomarkers crucial. Exosomal biomarkers may support diagnosis, prognosis prediction, and forecasting treatment response through liquid biopsy approaches.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges can limit generalizing exosomal biomarker findings in clinical practice?",{"text":72,"@type":64},"Key obstacles include variations in methodology, the diversity of studied sample types, and a concentration of research in specific populations. These factors complicate reproducibility and translation to broader clinical use.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352486,1790469683,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Review  \nExosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance  \nMaria Loukopoulou 1, Anastasia Kottorou 1, Angelos Koutras 2 and Foteinos-Ioannis Dimitrakopoulos 1,2, *  \nAcademic Editor: Andrea Nicolini  \nReceived: 12 January 2026  \nRevised: 7 February 2026  \nAccepted: 12 February 2026  \nPublished: 17 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Molecular Oncology Laboratory, Medical School, University of Patras, 26504 Patras, Greece; [maria.m.loukopoulou@gmail.com](maria.m.loukopoulou@gmail.com) (M.L.); [agathonisiotisa@yahoo.gr](agathonisiotisa@yahoo.gr) (A.K.)  \n2 Division of Oncology, Department of Medicine, University Hospital of Patras, 26504 Patras, Greece  \n* Correspondence: [fodimitrakopoulos@upatras.gr](fodimitrakopoulos@upatras.gr); Tel.: +30-26-1099-9535  \nAbstract  \nExosomes, acting as vital mediators of cellular communication and carriers of diverse biomolecular cargo, are increasingly documented as important participants in cancer pathogenesis and progression. When it comes to triple-negative breast cancer (TNBC), a disease that comes with significant therapeutic hurdles, finding new, non-invasive biomarkers is absolutely crucial. This systematic review considers recent research, focusing on the role of exosomal biomarkers in diagnosing, predicting prognosis and foreseeing treatment response in TNBC patients. After an extensive search across PubMed and Google Scholar, we found many exosomal molecules showing great promise for early detection, tracking disease progression and tailoring treatments. This truly highlights liquid biopsy as a valuable, minimally invasive tool. However, there are still some big challenges to treat. These include variations in methodology, the sheer diversity of samples studied and the prevalence of research in specific populations, all of which make it harder to generalize findings. It has been suggested that future research must prioritize protocol standardization, achieving a deeper understanding of underlying biological mechanisms and, crucially, developing combinatorial biomarker panels. Ultimately, the successful translation of exosomal biomarkers into clinical practice will significantly advance personalized medicine in TNBC, leading to improved patient outcomes and an enhanced quality of life.  \nKeywords: exosomes; cancer; TNBC; triple-negative breast cancer; extracellular vesicles  \n1. Exosomes: Silent Messengers of Cellular Communication  \nAt the heart of cellular communication and complex pathological interplays, exosomes seem to take on the role of tiny messengers capable of revolutionizing our understanding of intercellular dialogs [1] . Exosomes are nanovesicles that possess a spherical morphology, ranging between 30 and 150 nanometers, encased within a bilayer phospholipid membrane similar to typical cellular membranes [2] .  \nExosomes have been isolated from all body fluids (e.g., blood, plasma, cerebrospinal fluid, breast milk and even urine), making them easily accessible for clinical study [3] . In exosome research, plasma and serum are the most commonly used sources of bloodderived samples. The choice between them can have a significant impact on exosome yield, purity and the profile of molecular biomarkers [4] . Plasma is generally preferred because clotting during serum preparation activates platelets, leading to the release of additional extracellular vesicles that may contaminate the exosome fraction [5] . These differences can affect both the reproducibility and interpretation of results, emphasizing the importance of  \ncareful sample selection and standardized collection protocols, particularly when aiming for clinical applications [6] .  \nThese nanovesicles are secreted by cells dynamically and continuously under normal physiological conditions as w","cbCaigXTrgpl7SRG","https://ap.wps.com/l/cbCaigXTrgpl7SRG","pdf",953318,21,"English","# Abstract\n# Exosomes: Silent Messengers of Cellular Communication","[{\"question\":\"How do exosomes contribute to cellular communication relevant to cancer?\",\"answer\":\"Exosomes are nanovesicles that mirror the state of their parent cells and transfer information to distant cells and tissues. When cellular equilibrium is disrupted, such as in cancer, exosomes can foster pathological processes.\"},{\"question\":\"Why are exosomal biomarkers considered important for TNBC patients?\",\"answer\":\"TNBC faces significant therapeutic hurdles, making new non-invasive biomarkers crucial. Exosomal biomarkers may support diagnosis, prognosis prediction, and forecasting treatment response through liquid biopsy approaches.\"},{\"question\":\"What challenges can limit generalizing exosomal biomarker findings in clinical practice?\",\"answer\":\"Key obstacles include variations in methodology, the diversity of studied sample types, and a concentration of research in specific populations. These factors complicate reproducibility and translation to broader clinical use.\"}]","Exosomes and Triple-Negative Breast Cancer: Current Knowledge and Clinical Significance | PDF",1790099880,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7334a3160f0165eef8ace19a5eab19a3.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a33b5351229402b3463bdfdc7cb07bc6.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67cceb7922c371e7e8b6ddb5f48f96fd.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbdc5c99114bde85906aa3dd2dad6ee1.webp",980,1385]